Akonni Biosystems Inc.

Founded in 2003, Akonni Biosystems is a clinical molecular diagnostics (MDx) company that develops, manufactures, and intends to market its TruDiagnosis® product line within the healthcare sector. Akonni has been issued 21 US and 37 International patents primarily covering sample preparation, microfluidic devices, bioinstrumentation, and integrated systems. Product development has been supported by a series of government grants and contracts from federal agencies such as NIH, CDC, DOE, DoD, NIJ, and NSF. Commercial products in Akonni’s near-term pipeline include rapid sample preparation technologies for nucleic acid extraction and multiplex panel assays for detecting clinically relevant genotypes for pharmacogenomics, human chronic diseases, and genotypes for infectious diseases. Based on its recent analysis of microarray-based applications in the molecular diagnostics (MDx) market, Frost & Sullivan recognized Akonni Biosystems with the prestigious 2017 North American New Product Innovation Award.